Sign In
test

Jennifer Martin

Frazier Life Sciences Management, L.p.

Assets Managed
$3.887B
Holdings
38
Last Quarter
2026 - Q1
Filed Date
9d ago
Growth Rate
4.39%(2Q avg: 7.98%)
Sustained Growth
4 quarters

Portfolio positions

This chart displays the top 10 holdings in Frazier Life Sciences Management, L.p.'s 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 38 positions.

Assets under management

The assets under management (AUM) of Frazier Life Sciences Management, L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 3.887B in assets, with a quarterly growth rate of 4.39% and a 2-quarter average growth rate of 7.98%. The portfolio is managed by Jennifer Martin, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
MIRM
Mirum Pharmaceuticals Inc
Recent Activity
Increased 13.02%
18.26%
$709.449M
7.68M shares@ $92.39 avg price
NAMS
Newamsterdam Pharma Co Nv
Recent Activity
13.96%
$542.37M
16.944M shares@ $32.02 avg price
ERAS
Erasca Inc
Recent Activity
Increased 8.57%
10.28%
$399.245M
24.675M shares@ $16.19 avg price
BBIO
Bridgebio Pharma Inc
Recent Activity
Decreased -2.74%
6.59%
$256.059M
3.448M shares@ $74.26 avg price
ARQT
Arcutis Biotherapeutics Inc
Recent Activity
5.99%
$232.643M
9.875M shares@ $23.56 avg price
MBX
Mbx Biosciences Inc
Recent Activity
5.11%
$198.563M
6.652M shares@ $29.85 avg price
PHAT
Phathom Pharmaceuticals Inc
Recent Activity
3.57%
$138.503M
12.466M shares@ $11.12 avg price
MAZE
Maze Therapeutics Inc
Recent Activity
3.51%
$136.333M
4.567M shares@ $29.86 avg price
KRYS
Krystal Biotech Inc
Recent Activity
Decreased -1.46%
3.2%
$124.331M
481,307 shares@ $258.32 avg price
TRVI
Trevi Therapeutics Inc
Recent Activity
Decreased -3.11%
3.06%
$118.579M
9.94M shares@ $11.94 avg price

1-10 of 38